These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15459547)

  • 21. Hypertriglyceridaemia following adjuvant interferon-alpha treatment in two patients with malignant melanoma.
    Junghans V; Rünger TM
    Br J Dermatol; 1999 Jan; 140(1):183-4. PubMed ID: 10215802
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
    Kiley KE; Gale DM
    Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
    Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
    Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferons and malignant melanoma].
    Dreno B
    Rev Med Interne; 2002 Nov; 23 Suppl 4():489s-493s. PubMed ID: 12481404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186).
    Sulkes A; Schachter J
    Ann Oncol; 2002 Apr; 13(4):637. PubMed ID: 12056717
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
    Schaefer M; Horn M; Schmidt F; Schmid-Wendtner MH; Volkenandt M; Ackenheil M; Mueller N; Schwarz MJ
    Brain Behav Immun; 2004 Nov; 18(6):555-62. PubMed ID: 15331126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
    Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant interferon therapy in malignant melanoma].
    Mohr P
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L; Helmbold P; Emmert S; Marsch WC
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
    Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
    J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 33. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma.
    Herrera Saval A; Camacho Martínez F
    Acta Derm Venereol; 1999 Sep; 79(5):395. PubMed ID: 10494726
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
    Alonso-Pérez A; Ballestero-Díez M; Fraga J; García-Díez A; Fernández-Herrera J
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1328-9. PubMed ID: 17062055
    [No Abstract]   [Full Text] [Related]  

  • 35. Grand mal seizure induced by interferon-alpha-2b.
    Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
    [No Abstract]   [Full Text] [Related]  

  • 36. Interstitial pneumonitis and lung fibrosis during adjuvant treatment of melanoma with interferon alpha according to the Kirkwood schedule.
    Puente Vázquez J; Moreno Antón F; Grande Pulido E; López Tarruella-Cobo S; Pérez Segura P; Díaz-Rubio E
    Dermatology; 2005; 210(3):247-9. PubMed ID: 15785060
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma.
    Guillot B; Blazquez L; Bessis D; Dereure O; Guilhou JJ
    Dermatology; 2004; 208(1):49-54. PubMed ID: 14730237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
    Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
    Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cutaneous necrosis due to interferon alpha in a patient with melanoma].
    Aguilar García G; Serrano Falcón C; Serrano Falcón Mdel M; Carmona MD; Linares Solano J; Serrano Ortega S
    Actas Dermosifiliogr; 2006 Oct; 97(8):539-42. PubMed ID: 17067536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote-onset alopecia areata attributed to ipilimumab.
    Pearson DR; Lewis K; Alkousakis T
    Cutis; 2019 Dec; 104(6):E25-E27. PubMed ID: 31939941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.